financetom
THCP
financetom
/
Financials
/
THCP
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Thunder Bridge Capital Partners IV Inc.THCP
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Thunder Bridge Capital Partners IV Inc. does not have significant operations.

The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the financial services industry.

Thunder Bridge Capital Partners IV Inc. was incorporated in 2021 and is based in Great Falls, Virginia.

Latest News >
Homebuilder D.R. Horton's Q4 revenue beats estimates, EPS falls short
Homebuilder D.R. Horton's Q4 revenue beats estimates, EPS falls short
Oct 28, 2025
Overview * D.R. Horton ( DHI ) Q4 revenue beats analyst expectations, reaching $9.7 bln * EPS for Q4 misses analyst expectations, declining to $3.04 * Company recently increased quarterly dividend by 13% to $0.45 per share Outlook * D.R. Horton ( DHI ) expects fiscal 2026 revenues between $33.5 bln and $35.0 bln * Company anticipates closing 86,000 to...
Genomics firm GeneDx beats Q3 revenue estimates, raises outlook
Genomics firm GeneDx beats Q3 revenue estimates, raises outlook
Oct 28, 2025
Overview * GeneDx Q3 2025 rev grows 52% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company raises full-year revenue guidance to $425-$428 mln Outlook * GeneDx ( WGS ) raises full-year 2025 revenue guidance to $425-$428 mln * Company expects 53%-55% growth in exome and genome revenue for 2025 * GeneDx...
Merck-Eisai's cancer drug combo meets one main goal in late-stage study
Merck-Eisai's cancer drug combo meets one main goal in late-stage study
Oct 28, 2025
Oct 28 (Reuters) - Merck ( MRK ) and Eisai's ( ESALF ) experimental combination treatment for a type of kidney cancer met one of the main goals in a late-stage study, the drugmakers said on Tuesday. ...
Applied Industrial Technologies' Q1 sales beat; raises FY26 EPS forecast
Applied Industrial Technologies' Q1 sales beat; raises FY26 EPS forecast
Oct 28, 2025
Overview * Applied Industrial ( AIT ) fiscal Q1 sales rise 9.2% yr/yr, beating analyst expectations * Automation tech provider's net income for fiscal Q1 beats analyst estimates, reaching $100.8 mln * Company raises FY26 EPS guidance to $10.10-$10.85, reflecting Q1 performance Outlook * Company raises FY26 EPS guidance to $10.10-$10.85 * Company maintains FY26 sales growth guidance of 4%-7%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved